Johnson & Johnson
JNJ
#25
Rank
NZ$896.92 B
Marketcap
NZ$372.60
Share price
0.05%
Change (1 day)
43.94%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2026 (TTM): NZ$164.58 Billion

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM ) is NZ$162.14 Billion. In 2025 the company made a revenue of NZ$162.64 Billion an increase over the revenue in the year 2024 that were of NZ$157.49 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) NZ$164.58 B1.2%
2025 NZ$162.64 B3.27%
2024 NZ$157.49 B16.96%
2023 NZ$134.66 B-6.2%
2022 NZ$143.56 B4.57%
2021 NZ$137.29 B19.95%
2020 NZ$114.45 B-6.06%
2019 NZ$121.84 B0.18%
2018 NZ$121.62 B12.98%
2017 NZ$107.64 B3.72%
2016 NZ$103.78 B1.37%
2015 NZ$102.38 B7.92%
2014 NZ$94.86 B9.32%
2013 NZ$86.77 B6.19%
2012 NZ$81.71 B-1.93%
2011 NZ$83.32 B4.38%
2010 NZ$79.82 B-6.33%
2009 NZ$85.21 B-22.42%
2008 NZ$109.84 B37.73%
2007 NZ$79.75 B5.38%
2006 NZ$75.69 B2.42%
2005 NZ$73.90 B11.38%
2004 NZ$66.35 B3.04%
2003 NZ$64.39 B-7.15%
2002 NZ$69.35 B-11.37%
2001 NZ$78.25 B17.41%
2000 NZ$66.64 B25.18%
1999 NZ$53.24 B18.6%
1998 NZ$44.88 B15.12%
1997 NZ$38.99 B27.43%
1996 NZ$30.60 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
NZ$95.20 B-41.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$106.53 B-34.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$75.94 B-53.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$59.70 B-63.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$121.57 B-25.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$93.32 B-42.44%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ$49.54 B-69.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$42.26 B-73.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$110.66 B-31.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$74.31 B-54.17%๐Ÿ‡ฌ๐Ÿ‡ง UK